65.73
price up icon9.31%   5.60
after-market 시간 외 거래: 65.73
loading
전일 마감가:
$60.13
열려 있는:
$61.11
하루 거래량:
61,087
Relative Volume:
0.59
시가총액:
$611.21M
수익:
-
순이익/손실:
$-81.17M
주가수익비율:
-
EPS:
-
순현금흐름:
$-82.84M
1주 성능:
+3.95%
1개월 성능:
+95.68%
6개월 성능:
+12.86%
1년 성능:
+0.00%
1일 변동 폭
Value
$60.08
$66.01
1주일 범위
Value
$55.10
$66.01
52주 변동 폭
Value
$30.00
$98.00

Korro Bio Inc Stock (KRRO) Company Profile

Name
명칭
Korro Bio Inc
Name
전화
617-468-1999
Name
주소
ONE KENDALL SQUARE. BUILDING 600-700, CAMBRIDGE
Name
직원
101
Name
트위터
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
KRRO's Discussions on Twitter

Korro Bio Inc Stock (KRRO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-03-28 재확인 H.C. Wainwright Buy
2024-02-27 개시 BMO Capital Markets Outperform
2023-12-04 개시 H.C. Wainwright Buy
2023-11-29 개시 RBC Capital Mkts Outperform
2023-11-10 개시 Piper Sandler Overweight
2023-02-15 다운그레이드 Chardan Capital Markets Buy → Neutral
2023-02-13 다운그레이드 Cowen Outperform → Market Perform
2021-09-22 다운그레이드 Goldman Buy → Neutral
2021-01-27 업그레이드 JP Morgan Neutral → Overweight
2020-12-22 개시 B. Riley Securities Buy
2020-07-14 개시 Oppenheimer Outperform
2020-05-18 다운그레이드 JP Morgan Overweight → Neutral
2019-10-28 개시 Cowen Outperform
2019-10-28 개시 Goldman Buy
2019-10-28 개시 JP Morgan Overweight
모두보기

Korro Bio Inc 주식(KRRO)의 최신 뉴스

pulisher
Nov 04, 2024

Korro Bio (NASDAQ:KRRO) Shares Gap DownShould You Sell? - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Korro Bio, Inc. Announces Submission to Bellberry HREC for Phase 1/2 Clinical Study of KRRO-110 for AATD - Marketscreener.com

Nov 04, 2024
pulisher
Oct 28, 2024

Korro Bio (NASDAQ:KRRO) Trading Down 5.1%Time to Sell? - MarketBeat

Oct 28, 2024
pulisher
Oct 25, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for clinical leap - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for clinical leap By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 23, 2024

Korro Bio (NASDAQ:KRRO) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Korro Bio (NASDAQ:KRRO) Coverage Initiated at Raymond James - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

RBC lifts Korro Bio stock target on positive RNA editing outlook - Investing.com Australia

Oct 22, 2024
pulisher
Oct 22, 2024

Raymond James Initiates Coverage of Korro Bio (KRRO) with Strong Buy Recommendation - MSN

Oct 22, 2024
pulisher
Oct 21, 2024

Korro Bio price target raised to $105 from $95 at RBC Capital - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

RBC lifts Korro Bio stock target on positive RNA editing outlook By Investing.com - Investing.com South Africa

Oct 21, 2024
pulisher
Oct 21, 2024

Royal Bank of Canada Boosts Korro Bio (NASDAQ:KRRO) Price Target to $105.00 - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Korro Bio initiated with a Strong Buy at Raymond James - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Oct 21, 2024
pulisher
Oct 19, 2024

Korro bio CFO Vineet Agarwal sells $799,526 in stock - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

Insider Selling: Korro Bio, Inc. (NASDAQ:KRRO) CFO Sells 10,216 Shares of Stock - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Korro bio CFO Vineet Agarwal sells $799,526 in stock By Investing.com - Investing.com Australia

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio shares target lifted, buy rating on RNA editing potential - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio (NASDAQ:KRRO) Trading Down 4.1%Should You Sell? - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

HC Wainwright Increases Korro Bio (NASDAQ:KRRO) Price Target to $115.00 - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio price target raised to $115 from $100 at H.C. Wainwright - TipRanks

Oct 18, 2024
pulisher
Oct 17, 2024

BMO maintains steady target on Korro Bio shares By Investing.com - Investing.com Australia

Oct 17, 2024
pulisher
Oct 16, 2024

500: Something went wrong - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

180 Life Sciences, Korro Bio, NuScale Power: Retail Investors Turn Most Bullish On These Stocks - Barchart

Oct 16, 2024
pulisher
Oct 16, 2024

BMO maintains steady target on Korro Bio shares - Investing.com India

Oct 16, 2024
pulisher
Oct 16, 2024

What is KRRO’s price-to-sales ratio telling us about the company’s value? - US Post News

Oct 16, 2024
pulisher
Oct 16, 2024

Korro Bio (NASDAQ:KRRO) Shares Gap UpTime to Buy? - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Wall Street Analysts Think Korro Bio, Inc. (KRRO) Could Surge 239.54%: Read This Before Placing a Bet - Yahoo Finance UK

Oct 16, 2024
pulisher
Oct 16, 2024

RNA-Editing Stocks Soar on Wave Life’s Breakthrough Trial Data - Bloomberg

Oct 16, 2024
pulisher
Oct 15, 2024

Millennium Management LLC Purchases 23,307 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Korro Bio, Inc. (NASDAQ:KRRO) Short Interest Down 11.9% in September - MarketBeat

Oct 15, 2024
pulisher
Sep 30, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for growth - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society - The Manila Times

Sep 30, 2024
pulisher
Sep 30, 2024

Point72 Asset Management L.P. Raises Stock Position in Korro Bio, Inc. (NASDAQ:KRRO) - MarketBeat

Sep 30, 2024
pulisher
Sep 25, 2024

NEA Management Company LLC Boosts Stock Position in Korro Bio, Inc. (NASDAQ:KRRO) - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

19,148 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Bought by Bank of New York Mellon Corp - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

19,148 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Purchased by Bank of New York Mellon Corp - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Tri Locum Partners LP Takes Position in Korro Bio, Inc. (NASDAQ:KRRO) - MarketBeat

Sep 23, 2024
pulisher
Sep 20, 2024

Brown Brothers Harriman & Co. Acquires Shares of 813 Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Stock Surge: Corcept Therapeutics Inc (CORT) Closes at 40.92, Marking a -3.19 Increase/Decrease - The Dwinnex

Sep 20, 2024
pulisher
Sep 20, 2024

Korro Bio, Inc. Forecasted to Post Q3 2024 Earnings of ($2.79) Per Share (NASDAQ:KRRO) - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Korro Bio (NASDAQ:KRRO) Given "Outperform" Rating at Royal Bank of Canada - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Korro Bio (NASDAQ:KRRO) Given “Outperform” Rating at Royal Bank of Canada - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Novo Nordisk and Korro Bio Take RNA Editing to Cardiometabolic Diseases - Inside Precision Medicine

Sep 20, 2024
pulisher
Sep 19, 2024

Korvest Ltd Director Buys First Shares - TipRanks

Sep 19, 2024
pulisher
Sep 19, 2024

Korro Bio - The Pharma Letter

Sep 19, 2024
pulisher
Sep 19, 2024

ORGN stock touches 52-week high at $1.73 amid market optimism - Investing.com Australia

Sep 19, 2024
pulisher
Sep 19, 2024

Research Analysts Offer Predictions for Oruka Therapeutics, Inc.’s Q3 2024 Earnings (NASDAQ:ORKA) - Defense World

Sep 19, 2024

Korro Bio Inc (KRRO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):